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Genome-wide association studies of colorectal cancer (CRC) in Europeans and Asians have identified 21 risk sus-
ceptibility regions [29 indexsingle-nucleotidepolymorphisms(SNPs)].Characterizing theserisk regions indiverse
racial groups with different linkage disequilibrium (LD) structure can help localize causal variants. We examined
associations between CRC and all 29 index SNPs in 6597 African Americans (1894 cases and 4703 controls).
NineSNPsineight regions(5q31.1,6q26-q27,8q23.3,8q24.21,11q13.4,15q13.3,18q21.1and20p12.3) formally repli-
cated in our data with one-sided P-values <0.05 and the same risk directions as reported previously. We performed
fine-mappingof the21riskregions(including250 kbonbothsidesof the indexSNPs)usinggenotypedandimputed
markersat the density of the 1000 Genomes Project to search for additional or more predictive risk markers. Among
the SNPs correlated with the index variants, two markers, rs12759486 (or rs7547751, a putative functional variant in
perfect LD with it) in 1q41 and rs7252505 in 19q13.1, were more strongly and statistically significantly associated
with CRC (P < 0.0006). The average per allele risk was improved using the replicated index variants and the two
new markers (odds ratio 5 1.14, P 5 6.5 3 10216) in African Americans, compared with using all index SNPs
(odds ratio 5 1.07, P 5 3.4 3 10210). The contribution of the two new risk SNPs to CRC heritability was estimated
to be 1.5% in African Americans. This study highlights the importance of fine-mapping in diverse populations.
INTRODUCTION
Genome-wide association studies (GWAS) in European and
East Asian populations have identified 21 regions [characterized
by 29 index single-nucleotide polymorphisms (SNPs)] asso-
ciated with the risk of colorectal cancer (CRC) with P-values
,5 × 1028 (1–12). Like for other diseases/traits, many variants
identified from CRC GWAS fall outside of coding regions with
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no known biological function and they together only account for
a small proportion of CRC heritability (9,13). Findings from the
first wave of GWAS are expected to open up new windows into
disease biology; however, at present, the identities of the causal
variants remain undetermined for most risk loci. Studies in popu-
lations of African ancestry are likely to provide additional
insights in that: (i) it is possible to narrow the large chromosomal
regions of association and pinpoint the best risk-defining var-
iants, a benefit of the shorter average linkage disequilibrium
(LD) blocks in this population (14); and (ii) the greater genetic
diversity in African-descent populations may help to identify
additional susceptibility variants.
In this study, we tested the 29 GWAS-identified CRC risk
SNPs (21 regions) in a large sample set of African Americans
(1894 cases and 4703 controls) and searched for additional or
more predictive risk variants in the surrounding regions
(+250 kb) using genotyped and imputed markers at the
density of the 1000 Genomes Project (1KGP).
RESULTS
The African American CRC cases and controls in this analysis
are from seven studies/centers in the USA (Supplementary
Material, Methods and Table S1). Samples were genotyped
using the Illumina 1M-Duo bead array (except 170 subjects on
Omni 2.5 M). After quality control (QC) exclusions (see
Methods), the analysis was performed on 1894 cases and
4703 controls; the number of right colon, left colon and
rectal cases (mutually exclusive) was 778, 500 and 399, re-
spectively. On average, cases were older than controls
(mean 68 and 62 years, respectively) and the proportion of
females was higher in cases (49.6%, compared to 35.2% in
controls). Cases and controls were similar in global ancestry
distribution based on principal components (PCs) (Methods,
Supplementary Material, Fig. S1). We adjusted for age, sex
and the first four most important PCs in logistic regression
and little inflation of test statistics due to population stratifica-
tion was observed (genomic control l ¼ 1.04).
Among the 29 CRC risk variants (Table 1, Supplemen-
tary Material, Table S2), 27 were directly genotyped and
2 were imputed with R2 ≥ 0.90. All variants are common
[minor allele frequencies (MAFs) . 0.05] in African Amer-
icans. For 10 SNPs, minor alleles in Europeans or East
Asians are major alleles in African Americans. The
average difference in allele frequency was 0.18 (all ≤
0.41) (Fig. 1).
Table 1. Associations of the 29 index CRC risk variants in African Americans, with adjustment of age, gender and the first four principal components
SNP Locus BP (HG19) A1 A2 In published GWAS In African Americans
FRQa ORa FRQa ORa (95% CI) P (two-sided) ORa,b
rs6691170 1q41 222 045 446 T G 0.36 1.06 0.33 1.02 (0.93, 1.11) 0.72 1.02
rs6687758 1q41 222 164 948 G A 0.20 1.09 0.19 0.99 (0.90, 1.10) 0.86 0.99
rs10936599 3q26.2 169 492 101 T C 0.22 0.93 0.08 0.96 (0.82, 1.12) 0.62 0.98
rs647161c,d 5q31.1 134 499 092 A C 0.31 1.17 0.55 1.14 (1.05, 1.24) 0.002 1.14
rs1321311 6p21 36 622 900 A C 0.23 1.10 0.39 0.96 (0.89, 1.04) 0.34 0.96
rs7758229d,e 6q26-q27 160 840 252 T G 0.23 1.28 0.11 1.08 (0.95, 1.23) 0.056 1.21
rs16892766 8q23.3 117 630 683 C A 0.07 1.25 0.13 1.17 (1.05, 1.32) 0.0058 1.18
rs10505477 8q24.21 128 407 443 G A 0.54 0.85 0.19 0.91 (0.82, 1.01) 0.09 0.92
rs6983267 8q24.21 128 413 305 T G 0.51 0.83 0.13 0.87 (0.76, 0.99) 0.029 0.87
rs7014346 8q24.21 128 424 792 A G 0.37 1.19 0.39 1.05 (0.97, 1.13) 0.27 1.05
rs10795668 10p14 8 701 219 A G 0.33 0.89 0.07 0.98 (0.83, 1.15) 0.77 1.00
rs3824999 11q13.4 74 345 550 G T 0.50 1.08 0.20 1.15 (1.03, 1.27) 0.009 1.12
rs3802842 11q23.1 111 171 709 C A 0.29 1.11 0.35 1.04 (0.95, 1.12) 0.40 1.03
rs10774214d 12p13.32 4 368 352 C T 0.65 0.85 0.38 0.95 (0.87, 1.03) 0.19 0.95
rs7136702 12q13.13 50 880 216 C T 0.65 0.94 0.41 0.97 (0.89, 1.05) 0.41 0.96
rs11169552 12q13.13 51 155 663 T C 0.28 0.92 0.10 1.04 (0.91, 1.19) 0.58 1.07
rs4444235 14q22.2 54 410 919 C T 0.46 1.11 0.34 1.03 (0.95, 1.12) 0.45 1.03
rs1957636 14q22.2 54 560 018 C T 0.60 0.93 0.26 0.97 (0.89, 1.06) 0.54 0.97
rs16969681c 15q13.3 32 993 111 T C 0.10 1.18 0.13 1.16 (1.04, 1.31) 0.010 1.16
rs4779584 15q13.3 32 994 756 C T 0.81 0.74 0.46 0.98 (0.90, 1.06) 0.62 0.99
rs11632715 15q13.3 33 004 247 A G 0.47 1.12 0.38 1.04 (0.96, 1.13) 0.34 1.04
rs9929218 16q22.1 68 820 946 A G 0.29 0.92 0.29 0.93 (0.85, 1.02) 0.12 0.94
rs4939827 18q21.1 46 453 463 T C 0.53 1.18 0.32 1.07 (0.99, 1.17) 0.096 1.08
rs10411210 19q13.1 33 532 300 T C 0.10 0.87 0.41 0.94 (0.86, 1.02) 0.11 0.97
rs961253 20p12.3 6 404 281 A C 0.36 1.12 0.36 1.08 (1.00, 1.18) 0.054 1.09
rs4813802 20p12.3 6 699 595 G T 0.36 1.09 0.14 1.10 (0.98, 1.23) 0.11 1.07
rs2423279d 20p12.3_Asi 7 812 350 C T 0.30 1.14 0.34 0.94 (0.86, 1.03) 0.19 0.95
rs4925386 20q13.33 60 921 044 C T 0.69 1.08 0.28 1.05 (0.96, 1.15) 0.27 1.04
rs5934683 23p22.2 9 751 474 C T 0.62 0.93 0.28 1.00 (0.90, 1.11) 0.93 1.03
aFrequency (FRQ) and odds ratio (OR) for the A1 allele.
bOR further adjusted for local ancestry.
cImputed with R2 ≥ 0.90.
dPublished associations were in East Asians. Other published results were in Europeans.
eAssociation previously reported only with distal (left) colon cancer. Results in our study were also for distal colon cancer. No association was seen when all cancer
cases were pooled (OR ¼ 1.08, P ¼ 0.23).
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Given the strong prior evidence for the directions of these
genetic effects, we considered as statistically significant replica-
tion if the odds ratio (OR) estimates in African Americans were
of the same direction as reported in the original GWAS with a
one-sided P-value , 0.05 (or equivalently with a two-sided
P-value , 0.10). Nine variants were replicated at this level.
These included rs7758229 on 6q26-27 that was previously
reported to be associated only with distal (left) colon cancer in
East Asians [C/A, OR ¼ 1.28 in (2)]—in our data, the OR of
the risk allele C was 1.23 (95% CI: 1.00–1.51, two-sided P ¼
0.056 with 500 left colon cases and all controls). These 9 and add-
itional 15 variants showed the same direction of allelic risk as
reported before (24 of 29, 83%; Table 1). Estimated locus-
specific ancestry (see Methods) (including 250 kb on both
sides of the index variants) was not associated with CRC after ad-
justment for age, gender and the first four PCs—only two strong
associations were observed for 19q13.1 (P ¼ 0.003) and Xp22.2
(P ¼ 0.04). Results for the index SNPs were similar with or
without adjustment for local ancestry (Table 1).
Significant heterogeneity of effects across anatomic subsites
(left colon, right colon and rectal cancer) was detected for
rs10411210 at 19q13 and rs1321311 at 6p21 (Pheterogeneity ¼
0.03 and 0.04, respectively). Stratified analyses by site showed
that the rs10411210T allele was only associated with left colon
cancer (OR ¼ 0.83, 95% CI ¼ 0.72–0.95, P ¼ 0.007) and the
rs1321311 A allele was only associated with rectal cancer
(OR ¼ 0.85, 95% CI ¼ 0.73–0.99, P ¼ 0.03). These site-
specific effects were of the same direction as reported in the
initial GWAS.
Even with the large sample size, our power to detect the pre-
viously reported effect sizes was .80% for only 15 of the 29
index variants at a one-sideda level 0.05 (Supplementary Mater-
ial, Table S2); among these, 7 were successfully replicated. One
possible reason of non-replication could be that the biologically
relevant variants are in LD (correlated) with the index variants in
the original GWAS population, yet not so in African Americans.
Therefore, a complete search among the correlated variants for
stronger associations with CRC is necessary. We performed fine-
mapping in the 21 risk regions/loci (+250 kb of index variants)
using genotyped and imputed data (see Methods). We catalo-
gued SNPs that were correlated (r2 . 0.2) with the index
signals from 1KGP [Europeans (EUR) or Asians (ASN) depend-
ing upon the initial GWAS population] and tested their associa-
tions with CRC using locus-specific a levels, calculated as 0.05
divided by the ‘effective’ number of independent markers in the
1KGP Africans (AFR) population among the correlated markers
in each region (see Methods and Table S3 for locus-specific a
levels). This strategy was to balance between the need to
correct for multiple comparisons and the prior knowledge that
these regions are known to be important for CRC risk.
Among the correlated SNPs, two variants in the 1q41 and
19q13.1 loci passed the significance threshold (Table 2). Specif-
ically, at 1q41, the original risk variants rs6691170 and
rs6687758 were not replicated in African Americans (OR ¼
1.02 and 0.99, P . 0.7, power ≤ 56%); rs12759486 (T/C)
located between the two was much more strongly associated
with CRC (OR ¼ 0.86, 95% CI ¼ 0.79–0.93, P ¼ 1.5 ×
1024) in our study (Fig. 2). Rs6691170 and rs6687758 were in
low LD with each other (r2 ¼ 0.13, D′ ¼ 0.59) in EUR and the
original GWAS in Europeans (4) suggested that they may repre-
sent independent signals of association. From LD structure based
on 1KGP data, rs6691170 and rs6687758 are in separate (but
not completely distinct) LD blocks in both EUR and AFR
(Supplementary Material, Fig. S2). Rs12759486 is located
between the two and is in moderate LD with both of them in
EUR (r2 ¼ 0.37 and 0.22, respectively) but not so in AFR
Figure 1. Allele frequencies in published reports (blue for Europeans and yellow for East Asians) and in African Americans (red). SNPs replicated in African Amer-
icans are marked with an asterisk.
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(r2 , 0.004, D′ , 0.01). Rs12759486 maps within an intron of
the lincRNA RP11-815M8.1. Although the function of this
RNA is unknown, it is expressed in colon tissue (Human
BodyMap 2.0 data from Illumina). Interestingly, a nearby
SNP, rs7547751, 827 bp upstream and in perfect LD with
rs12759486 in both EUR and AFR (r2 ¼ 1.0), was equally asso-
ciated with CRC (P ¼ 1.7 × 1024, OR ¼ 0.85 for major allele
C). Rs7547751 maps to H3K4me1 and H3K27Ac enhancer
peaks with a nearby DNAse I peak and CTCF and cohesion/
Rad21 binding sites determined by ChIP-seq (15). Based on
these data, it is possible that this enhancer may modulate
lincRNA RP11-815M8.1 or a protein-coding gene in trans.
At 19q13.1 in African Americans, the published hit,
rs10411210, had a P-value of 0.11 using all cases combined
(OR ¼ 0.94, 95% CI¼ 0.86–1.02, power ¼ 0.97). Rs7252505,
43 kb downstream from rs10411210, was more strongly asso-
ciated with CRC (OR ¼ 0.85, 95% CI ¼ 0.78–0.93, P ¼
1.8 × 1024) in African Americans (Fig. 3). Rs7252505 and
rs10411210 were correlated in EUR (r2 ¼ 0.77, D′ ¼ 0.88) but
not so in AFR in 1KGP (r2 ¼ 0.05, D′ ¼ 0.44) (see Supplemen-
tary Material, Fig. S3 for LD structure in 1KGP).
These results raise the possibility that the original GWAS
signals in 1q41 and 19q13 may not have captured the best
predictive risk markers. Results for the two best markers in
African Americans did not change much (,3% change in
ORs) after conditioning on the index variants or after adjusting
for local ancestry.
We also looked for new independent associations among var-
iants that were uncorrelated (r2 , 0.2) with the index SNPs
in the initial GWAS populations, using a significance level of
2.8 × 1026, which is 0.05/the total number of ‘effective’
markers across the 21 risk regions in the 1KGP YRI population
(Methods and Table S3). We did not find any statistically signifi-
cant associations among SNPs in this category.
To model the cumulative effects of CRC risk variants, we con-
structed a risk score by summing all independent risk alleles
(OR .1) and estimated the average per allele risk (see
Methods). We compared the results from summing all
GWAS-identified risk variants (n ¼ 21 independent) and from
summing the variants that were replicated (n ¼ 7) or newly dis-
covered (n ¼ 2) in African Americans (Methods and Table 3),
excluding the one SNP on 6q26-q27 that was only associated
with distal colon cancer in the original GWAS (2). From 21
GWAS index variants, the per allele OR was 1.07 (95% CI:
1.05–1.09, P ¼ 3.4 × 10210); the OR for the highest versus
the lowest quartile of the risk score was 1.72 (95% CI: 1.44–
2.06, P ¼ 1.9 × 1029). As expected, there was a slight increase
in relative risk when summing risk variants replicated or newly
discovered inAfrican Americans: the perallele ORwas 1.14 (95%
CI: 1.10–1.18, P ¼ 6.5 × 10216) and the OR for the highest
versus lowest quartile of the score was 1.83 (95% CI: 1.55–
2.16, P ¼ 1.1 × 10212). The risk score effect did not differ
across left colon, right colon or rectal cancer (Pheterogeneity ¼ 0.54).
The two novel variants rs12759486 and rs7252505 contribu-
ted approximately 1.5% of the heritability of CRC (see
Methods), estimated in African Americans.
DISCUSSION
It is important to assess the strength and robustness of
GWAS-identified association signals in diverse ethnic
Table 2. Associations with CRC at the two regions where a statistically significant better SNP was discovered in African Americans
Region Name (BP) A1/A2/A1 Frequency OR (95% CI)a P-value Index SNP from initial
GWAS (BP)
r2 with index SNP
in EUR/AFR
1q41 rs12759486 (222 066 536) T/C/0.58 0.86 (0.79, 0.93) 1.5 × 1024 rs6691170 (222 045 446)b 0.37/0.004
0.85 (0.79, 0.92)c 9.4 × 1025
19q13.1 rs7252505 (33 575 064) A/G/0.62 0.85 (0.78, 0.93) 1.8 × 1024 rs10411210 (33 532 300) 0.77/0.05
0.84 (0.76, 0.93)c 6.0 × 1024
Analysis was adjusted for age, sex and the first four PCs. Both SNPs were imputed with R2 . 0.97. EUR and AFR are European and African samples from the 1000
Genomes Project.
aORs are for A1 allele.
bSelected from the two index SNPs in this region based on a smaller P-value.
cAnalysis conditioning on the index SNPs from the initial GWAS study.
Figure 2. P-value plot for the 1q41 risk locus. The SNP with the smallest P-value
in African Americans, rs12759486, is shown as a purple diamond. r2 is in relation
to this SNP in EUR from the 1000 Genomes Project. Grey circles are SNPs with
no r2 estimation due to low MAF or because the SNP is not in older versions of the
1000 Genomes data. The plot was generated using LocusZoom (16).
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populations. This study, to our knowledge, is the first to replicate
and characterize risk variants identified from CRC GWAS (all in
European and Asian populations) in African Americans with a
relatively large sample size. Nine associations were statistically
significantly replicated with the same direction of effects as pre-
viously reported (one-sided P , 0.05). We also identified var-
iants in 1q41 (rs12759486 or rs7547751, two SNPs in perfect
LD) and 19q13.1 (rs7252505) that were more strongly related
to CRC in African Americans than the index variants (three
orders of magnitude change in P-value). These two new risk var-
iants explained roughly 1.5% of overall CRC heritability in
African Americans and improved on cumulative risk modeling.
Failure to replicate other previous associations may be due to low
study power (,80% for half of the variants) or to differences in
LD patterns between the causal variant and the identified marker
between populations—the latter is a known cause for direction-
ally inconsistent associations across studies (a.k.a. the flip-flop
phenomenon) (17). No statistically significant reverse associ-
ation was noted, however.
We detected significant heterogeneity of effects across left
colon, right colon and rectal cancer for rs10411210 in RHPN2
at 19q13 and rs1321311 near CDKN1A at 6p21 (Pheterogeneity ,
0.05). Although they were not statistically significantly repli-
cated when all cases were pooled, rs10411210 was associated
with left colon cancer and rs1321311 with rectal cancer (P’s ,
0.05) in African Americans. In the GWAS where rs10411210
was first reported for CRC association, there was no mention
of effect heterogeneity across subsites (although the between-
study heterogeneity seemed high) (5). Several replication
studies conducted in Northern Chinese (18), Southern Chinese
(19), Hong Kong subjects (20) and in a Swedish-based cohort
(21) have been published for rs10411210; however, none of
these replicated the association or reported on differences in
effect across subsites. A reason for failure to replicate may be
due to effect heterogeneity. In a study (1000 cases) on clinical
and morphological characters of CRC tumors and genetic vari-
ation, the TT genotype of rs10411210 was associated with des-
moplastic reaction, which is generally considered favorable for
survival (22). For rs1321311, we did not find studies including
specific results other than the original GWAS, which only
reported that this SNP was not associated with tumor location
(colon and rectum). Risk heterogeneity by CRC subsites has
been previously reported for GWAS index variants. For
example, the risk for rs4939827 was greater for rectal cancer
than for colon cancer in a GWAS (statistically non-significant
heterogeneity) (7); yet, in a replication study in Europeans,
this SNP was associated with distal colon cancer but not prox-
imal or rectal cancer (Pheterogeneity ¼ 0.03) (23). In our data,
there did not seem to be effect heterogeneity for rs4939827 by
subsites (P ¼ 0.23). However, for the SNP rs7758229 at 6q26
that was reported to be only related to left colon cancer in a
GWAS in East Asians (2), no heterogeneity across sites was
found in our data (Pheterogeneity ¼ 0.35), even though we repli-
cated its association with left colon cancer (one-sided
P , 0.05) and not with right-sided colon or rectal cancers
(P’s . 0.41). Sample size could be a reason for these inconsist-
encies and additional large replication studies are needed.
At 19q13 (index SNP rs10411210), rs7252505 was more
strongly associated with CRC in African Americans, with
no evidence of heterogeneity across anatomical subsites
(Pheterogeneity ¼ 0.78). While rs10411210 is located in RHPN2,
rs7252505 is in an intron of the neighboring gene GPATCH1. Al-
though GPATCH1 is expressed in the colon, little is known
about its function other than the fact that it contains a
G-patch domain, a domain typically associated with RNA pro-
cessing. Rs7252505 or SNPs in high LD (r2 . 0.8) with it in
1KGP AFR do not map to any ChIP-seq peaks marking
Figure 3. P-value plot for the 19q13 risk locus. The SNP with the smallest P-value
in African Americans, rs7252505, is shown as a purple diamond. r2 is in relation to
this SNP in EUR from the 1000 Genomes Project. Grey circles are SNPs with no r2
estimation due to low MAF or because the SNP is not in older versions of the 1000
Genomes data. The plot was generated using LocusZoom.
Table 3. Effects of summary risk score on CRC risk in African Americans
Quartiles Using index GWAS SNPs (n ¼ 21) Using risk SNPs in African Americans (n ¼ 9)
Ca/Coa OR (95% CI) P-value Ca/Coa OR (95% CI) P-value
Q1 271/862 1.00 (ref.) — 380/1270 1.00 (ref.) —
Q2 428/1133 1.29 (1.07, 1.56) 0.008 469/1180 1.63 (1.38, 1.93) 0.0001
Q3 516/1298 1.36 (1.13, 1.63) 0.001 504/1147 1.40 (1.18, 1.65) 6.8 × 1029
Q4 679/1410 1.72 (1.44, 2.06) 1.9 × 1029 541/1106 1.83 (1.55, 2.16) 1.1 × 10212
aCa/Co, numbers of cases/controls.
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enhancers or other regulatory elements in colon cancer cell
lines. The functional basis for the rs7252505 signal is, thus,
not apparent at this stage. Only one CRC study in Spanish sub-
jects reported on rs7252505; however, the association with
CRC was non-significant (P ¼ 0.36) and no allelic risk esti-
mate was presented (24).
Our approach of separating SNPs that are in LD from those
not in LD with the index SNPs and testing the two groups with
different significance thresholds was a reasonable balance
between prior knowledge and the need for multiple comparison
adjustment. However, the two groups may not have been cor-
rectly defined even with the detailed coverage featured by cur-
rently available public data. For example, we replicated the
index SNP rs16892766 at 8q23 with a P-value 0.006 (minor/
major ¼ C/A, MAF ¼ 0.13, OR ¼ 1.17). Another SNP,
rs16892769, with a much smaller P-value (minor/major ¼ G/
T, MAF ¼ 0.12, OR ¼ 1.31, P ¼ 1.5 × 1025, imputation
R2 ¼ 0.91) is located just 131 bp from rs16892766 (see Supple-
mentary Material, Fig. S4 for P-value plot and Supplementary
Material, Fig. S5 for LD structure in 1KGP EUR and AFR).
After conditioning on each other, the P-values became even
smaller (1026 for rs16892769 and 0.0004 for rs16892766)
and did not change much with additional adjustment for local
ancestry. Generally, SNPs within such short distance are
likely inherited together because physical chromosomal struc-
ture typically prevents recombination events. In 1KGP AFR,
the two SNPs are indeed in high LD (D′ ¼ 1, r2 ¼ 0.05, P ,
0.0001 from Pearson’s correlation test). However, because
rs16892769 was monomorphic in Europeans in both HapMap
and 1KGP, no LD estimation was available; hence,
rs16892769 was defined as ‘uncorrelated’ with the index
variant and did not pass the corresponding more stringent
significance threshold. Given its rarity or non-existence in
Europeans, rs16892769 is unlikely a causal variant in this popu-
lation. In African Americans, haplotype analysis revealed three
common haplotypes AT, AG and CT, with frequency 0.75, 0.12
and 0.13, respectively; compared to AT, the haplotype AG had
an OR of 1.30 (P ¼ 3.2 × 1025), suggesting some independent
effect for the G allele of rs16892769. There has been no report on
the association between rs16892769 and CRC. However, this
SNP may be worth investigating in future studies in light of
our results. On the other hand, the threshold (r2 . 0.2) for
defining markers correlated with the index variants may be
too low. If a higher threshold is used (such as r2 . 0.4), our
best marker at 1q41, rs12759486, would be classified as
‘non-correlated’ and would not pass the more stringent signifi-
cance level for this category. Hence, some caution should be
exercised in interpreting our results. On a related note, the
effect sizes of our two best SNPs (rs12759486 and
rs7252505) may be over-estimated due to the ‘winner’s
curse’ (25–27).
In summary, we confirmed in African Americans the risk
directions for 83% of the 29 CRC variants identified in previous
GWAS and successfully replicated an association for nine of
them. No population-specific (except for the possibility of an
association with rs16892769) or novel risk loci were discov-
ered. However, at two known loci, we identified two markers
that may better define CRC risk than the previous index
SNPs. Replication in additional studies is required to confirm
these effects.
MATERIALS AND METHODS
Subjects and genotyping and QC
DNA samples were available for 7339 African Americans (2066
CRC cases, 5273 CRC-free controls) from the following studies/
centers: the Multiethnic Cohort study (MEC, 442 cases and 4620
controls), Colorectal Cancer Family Registry (CCFR, 999 cases
and 290 controls), the Southern Community Cohort Study
(SCCS, 164 and 160 controls), MD Anderson Cancer Center
(189 cases), the University of North Carolina CanCORS study
(UNC-CanCORS, 84 African American cases), the North Caro-
lina Rectal Cancer Study (UNC-Rectal, 112 cases and 108 con-
trols), the Prostate, Lung, Colorectal, and Ovarian Cancer
Screening Trial (PLCO, 76 cases and 95 controls). See Supple-
mentary Material for details on sample recruitment and data col-
lection.
Except for the PLCO subjects (see below), 7168 samples were
genotyped using the Illumina 1M-duo bead array at the USC Epi-
genome Center. Samples were excluded in the following situa-
tions: (i) call rates , 95% (n ¼ 167), (ii) no age information
(n ¼ 2), (iii) gender mismatch (n ¼ 39), i.e. when the reported
gender is different from that estimated based on X chromosome
inbreeding coefficient F (calculated by PLINK), (iv) ancestry
outliers (n ¼ 98) based on PCs (discussed below), and (v)
closer than second-degree relatives (n ¼ 435), where relation-
ships were derived from estimated probabilities of sharing 0, 1
or 2 allele based on genomic data (calculated by PLINK). Rela-
tives were removed in the following order or priority: (i) subjects
with many relatives, (ii) controls, (iii) samples with lower call
rates. Sample replicates (2%) were included and the average con-
cordance rates were .99.9%. Starting from 1 192 666 markers,
we excluded markers of poor clustering property or with call
rates ,95%, MAFs ,0.005, more than one discordant pair
among sample replicates, and P-values , 10210 from the
Hardy-Weinberg equilibrium test in MEC controls and of poor
clustering quality. These resulted in 6427 subjects (4609 con-
trols and1818 cases) on 1 049 327 markers.
PLCO subjects (n ¼ 171) were genotyped by the NCI geno-
typing center on the Illumina Omni 2.5 M array and were
pre-filtered by the PLCO data coordinating center using
similar criteria as described above. We removed one subject to
get rid of closer than second-degree relatives. For this analysis,
76 cases and 94 controls on 527 383 markers that overlapped
with other studies were retained. Allele frequencies matched
well between PLCO and MEC controls (only 77 differences
were .0.1 and all were ≤0.13).
Statistical analysis
Association testing
Logistic regression of allelic dosage with adjustment for age at
blood draw, sex and the first four PCs was performed to estimate
the OR and 95% CI of per increase in allele count, where age was
grouped as ,55 years, 5-year intervals from 55 to 80, and ≥80
years. Heterogeneity of genetic effects across left colon, right
colon and rectal cancer (mutually exclusive) was assessed with
multinomial logistic regression with SAS 9.2. PCs were calcu-
lated using similar methods as in (28) with our own R
program, based on about 22 000 SNPs with inter-marker dis-
tance .100 kb. Unrelated HapMap CEU, YRI and JPT were
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included as population controls to associate PCs with continental
ancestries—PC1 was an indicator for European ancestry. Ethni-
city outliers were identified on PC plots by visual inspection. The
distribution of PCs was similar among all cases and controls after
the outliers were removed (Supplementary Material, Fig. S1).
The first six PCs sequentially accounted for 2.35, 0.52, 0.10,
0.10, 0.09 and 0.09% of the total variation, which, together
with pair-wise PC plots, suggested that the first four PCs were
most informative for global ancestry. All P-values presented
are two-sided, unless otherwise noted.
Local ancestry estimation
The percentage of African ancestry (0, 50 or 100%, i.e. half of the
estimated number of African chromosomes) was inferred for
each participant at each marker location with the LAMP
program v2.4 (29). For the one region on Chromosome X,
local ancestry was separately estimated for males and females.
To summarize local ancestry at a CRC risk region, for each indi-
vidual we averaged across all local ancestry estimates that are
within the start and end points of the region (Supplementary Ma-
terial, Table S3). We evaluated whether ORs changed with and
without adjustment for local ancestry in logistic regression.
Since they did not change materially, we presented results
without adjustment for local ancestries, unless otherwise noted.
Imputation
Prediction of un-genotyped SNPs was performed with BEAGLE
3.3 (30) based on the 1000 Genomes EUR and AFR reference
panels (phase 1, release 3). Markers with MAFs ,0.005 in
both EUR and AFR reference panels were excluded from imput-
ation. 10 050 748 markers with imputation accuracy R2 . 0.8
were kept for association analysis.
Fine mapping
We conducted fine mapping in regions within 250 kb of previ-
ously identified risk variants. If the regions overlapped for mul-
tiple risk variants (i.e. when they are ,500 kb apart), one larger
region was formed from 250 kb upstream of the first to 250 kb
downstream of the last variant (see Supplementary Material,
Table S3 for risk regions). For each region, we catalogued
SNPs that were correlated (r2 . 0.2) with the index signal in
the initial GWAS population (EUR or ASN) in 1KGP (phase
1, release 3). Locus-specific significance levels, 0.05/the ‘effect-
ive’ number of independent markers in the 1KGP AFR popula-
tion among the correlated markers in each region, were used to
declare a better marker than the index SNPs in a region. For var-
iants that were uncorrelated with the index signal in the initial
GWAS populations (r2 , 0.2), we estimated the total number
of effective markers across all risk regions in 1KGP YRI and
used a significance level of 2.8 × 1026 (0.05/the total number
of independent SNPs) in claiming novel association signals.
The number of markers correlated and uncorrelated with previ-
ous hits and the ‘effective’ number of SNPs in each region are
shown in Supplementary Material, Table S3. The number of in-
dependent SNPs was estimated with Keffective (31).
We performed stepwise logistic regression to select among
SNPs (dosages) in each region separately for correlated and
uncorrelated SNPs, using the significance levels described
above. To preserve sample size, sporadic missing values for gen-
otyped markers were replaced with mean allele dosages in their
corresponding sex group. One SNP from locus 6q26-27 was pre-
viously reported to be associated only with distal (left) colon
cancer in East Asians (2) so only association with distal colon
cancer was assessed for this variant, unless otherwise noted.
Risk modeling
A risk score was calculated summing the risk (OR . 1) alleles
from independent markers. The OR of per one allele increase in
the risk score was estimated as an average cumulative risk of
all contributing markers. Here, we excluded the one SNP on
6q26-q27 associated with only distal colon cancer in the original
GWAS. This sum was calculated first based on previous GWAS
hits (n ¼ 21). There are six regions containing multiple risk
SNPs; these SNPs are in LD (r2 . 0.2) in the initial GWAS popu-
lationexcept the two in20p12.3 (defined inTable1).BothSNPs in
20p12.3 were included; for the remaining five regions, the SNP
with the smallest P-value was included since likelihood ratio
tests showed that the contribution of other variants in the same
region was not important (x2’s , 0.69, P’s . 0.41). Independ-
enceof SNPson the samechromosomewas confirmedbycompar-
ing regression coefficients from single variant analysis and from
the model including all markers on the same chromosome. A
sum was similarly calculated with the variants replicated (n ¼ 7
independent) and newly identified (n ¼ 2) in African Americans.
Missingvalues forungenotypedmarkerswerereplacedwithmean
allele dosages in their corresponding sex group.
Heritability explained by the newly discovered variants
in African Americans
The sibling relative risk attributable to a given SNP was calcu-
lated using the formula as in (9,32), l∗ ¼ ( p( pr2 + qr1)2+
q( pr1 + q)2)/( p2r2 + 2pqr1 + q2)2,where p is the population
frequency of the risk allele (OR . 1), q ¼ 1 2 p, and r1 and r2
are the relative risks (estimated as OR) for heterozygous and
homozygous genotypes containing the risk allele. For imputed
markers, we used the probabilities of heterozygotes and homo-
zygotes in regression models to obtain r1 and r2. Assuming a
multiplicative effect, the proportion of the familial risk attribut-
able to a SNP was calculated as log(l∗)/log(l0), where l0 is the
overall familial relative risk estimated from epidemiological
studies of CRC, assumed to be 2.2 (32,33).
SUPPLEMENTARY MATERIAL
Supplementary Material is available at HMG online.
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